CD8A and alopecia areata: PBMC from patients with progressive alopecia areata reveal a higher percentage of CD4+ CD25+ CD154+ T-cells that suppress the proliferative activity of CD8+ PBMC to a much lesser extent when compared with CD4+ CD25+ PBMC of health donors or patients with stable or regressive alopecia areata.